Pro-epil expression level in a biological sample as testicular cancer biomarker, particularly in combination with the hcbeta and afp biomarkers

The present invention is directed to the use of the expression level of the pro-EPIL gene as a biomarker for the diagnosing of testicular cancer, particularly a testicular germ cell tumor. The invention also relates to an in vitro method for detecting and/or classifying a testicular cancer in a subject comprising...